Please assess the completion status of the following clinical trial:

Trial Title: Role of Zinc in Recurrent Acute Lower Respiratory Infections

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Children aged 6 to 59 months with documented recurrent acute lower respiratory infection i.e., more than two episodes of ALRI in one year or more than three episodes in any time frame.~Exclusion Criteria:~* Children with congenital heart diseases~* Children with congenital anomalies which can cause recurrent chest infection~* Children with Tuberculosis~* Children with bronchial asthma or hyperactive airway disease~* Children with WZS \< -2 of HZS \< -2 as per WHO standards~* Children with any diarrhoeal episode in past 3 months~* Children having receive any zinc supplementation in past 3 months~* Children who did not turn up on follow up and could not be contacted were excluded from the study.

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 59 Months
- Healthy Volunteers: f

Study Arms:
- Zinc group (Type: EXPERIMENTAL): children with recurrent acute lower respiratory infections receiving zinc supplementation
- Placebo group (Type: PLACEBO_COMPARATOR): children with recurrent acute lower respiratory infections receiving placebo syrup

Based on this trial design, predict the completion outcome and termination type (if applicable).